Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose ketamine for prevention of postoperative shivering after abdominal hysterectomy
IRCT20190409043219N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine in postanesthetic shivering (PAS) (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Incidence of postoperative shivering after total abdominal hysterectomy and Severity of postoperative shivering after total abdominal hysterectomy. Started May 2019; status: completed.
02
Drugs
ketamine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20190409043219N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190409043219N1.